For condition: Alopecia
For condition: Androgenetic Alopecia
Women’s Androgenetic Alopecia Study (14 Months)
Study Summary
Who Can Participate?
Women aged 18 to 65 with mild to moderate androgenetic alopecia may participate.
Inclusion Criteria
• have a clinical diagnosis of mild to moderate AGA
• willing to maintain the same hair care regimen with the same hair care products throughout the study
• willing to maintain at least ¼ inch length hair during the study with the same hairstyle, hair length, and hair color throughout the study
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating androgenetic alopecia (11 visits)
• Will receive either an investigative oral treatment (study drug) or an inert tablet
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• 62 weeks
Note: Participants will need to stop all other treatments for androgenetic alopecia during clinical trial participation. Some over-the-counter preparations may be deemed acceptable by the doctor performing the study.
For more information about this trial, please visit ClinicalTrials.gov
